In the Company of Wolves by James Michael Larranaga

In the Company of Wolves: Thinning the Herd is another advanced review copy from Net Galley.

Book Description:  Quin Lighthorn was released from a mental institution in order to help the FBI with an undercover operation—or so he thought. As part of Lighthorn’s undercover job, he becomes an intern at Safe Haven, a firm that pays out a portion of a life insurance plan to a terminally ill person so long as that person makes the firm the insurance policy’s beneficiary. Within minutes of his first day on the job, Lighthorn witnesses a murder. From there, the plot begins to unravel…

Well...from the beginning the novel seemed a bit off.  Quin wasn't really believable, and the strange set up of Safe Haven, the company that provides accelerated benefits for the terminally ill, wasn't in the least believable.  Now, while it is certainly possible to receive accelerated benefits if your policy provides for it (and there are viatical or life settlement companies that buy policies),  Safe Haven from the beginning is obviously a criminal enterprise that buys the policy, then collects on the death of the policy owner.  And Safe Haven has no intention of waiting very long, as Quin realizes on his first day on the job.

Note:  Quin's lack of believability is somewhat explained later in the book.

I'm pretty good at suspending disbelief, but only if the writing and the plot are good enough to provide enjoyment and if I don't interrupt my reading with constant "Say, what???" thoughts.  Not the case with In the Company of Wolves....

It did interest me that in the end, there was a promise of another novel.
This plot was wrapped up, more or less, but another adventure for the nebulous Quin is indicated.  Could the series improve?  I'm not sure if that is possible, but perhaps getting the weirdness of Quin out of the way in the first novel may leave an opening.

After searching for a link to the novel on various sites, I finally realized that Createspace is a self-publishing company.

Mystery.  Sept. 2013.